Akebia Therapeutics Inc banner

Akebia Therapeutics Inc
NASDAQ:AKBA

Watchlist Manager
Akebia Therapeutics Inc Logo
Akebia Therapeutics Inc
NASDAQ:AKBA
Watchlist
Price: 1.31 USD 8.26% Market Closed
Market Cap: $347.6m

Cash Flow Statement

Cash Flow Statement
Akebia Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(12)
(10)
(13)
(22)
(27)
(33)
(37)
(38)
(41)
(51)
(61)
(76)
(101)
(118)
(136)
(154)
(140)
(127)
(77)
(56)
(68)
(71)
(144)
(193)
(217)
(245)
(280)
(268)
(386)
(391)
(383)
(392)
(300)
(299)
(283)
(276)
(163)
(156)
(93)
(56)
(97)
(60)
(52)
(44)
(40)
(46)
(69)
(45)
(36)
(16)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
2
12
21
31
39
39
39
36
34
33
33
36
38
38
38
38
38
38
38
38
38
38
38
38
38
28
19
10
Stock-Based Compensation
0
1
2
4
5
6
6
5
4
4
5
5
5
5
6
7
8
8
9
9
9
9
19
19
19
19
12
15
19
23
24
26
25
24
23
21
22
19
18
16
12
11
9
9
8
8
8
8
8
10
Other Non-Cash Items
0
(0)
(0)
4
5
6
6
5
5
5
5
5
6
6
7
11
12
12
13
9
9
9
36
51
71
92
89
88
229
229
253
263
138
118
100
85
57
78
(7)
(14)
(22)
(45)
12
13
13
23
31
36
50
47
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
0
0
7
0
0
0
6
0
0
0
5
0
0
0
Change in Working Capital
1
2
2
2
1
3
3
3
1
8
3
44
54
51
187
174
210
170
7
(21)
(24)
22
8
(86)
(138)
(117)
(106)
(68)
(16)
(45)
(14)
5
(64)
(76)
(108)
(51)
(103)
(42)
(11)
(36)
47
(8)
(21)
(32)
(49)
(53)
(40)
(54)
(36)
(9)
Cash from Operating Activities
(11)
N/A
(8)
+22%
(11)
-35%
(16)
-40%
(21)
-30%
(23)
-13%
(27)
-18%
(30)
-9%
(35)
-18%
(39)
-10%
(52)
-35%
(27)
+49%
(41)
-56%
(61)
-46%
58
N/A
31
-47%
82
+166%
56
-32%
(56)
N/A
(67)
-19%
(82)
-23%
(40)
+51%
(97)
-143%
(215)
-121%
(262)
-22%
(239)
+9%
(257)
-8%
(209)
+19%
(134)
+36%
(172)
-29%
(110)
+36%
(92)
+17%
(192)
-110%
(221)
-15%
(253)
-14%
(204)
+19%
(171)
+16%
(81)
+53%
(73)
+10%
(69)
+6%
(35)
+50%
(76)
-118%
(23)
+69%
(25)
-8%
(39)
-54%
(38)
+1%
(41)
-6%
(35)
+14%
(2)
+93%
32
N/A
Investing Cash Flow
Capital Expenditures
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(2)
(3)
(3)
(3)
(2)
(1)
(2)
(1)
(2)
(1)
(2)
(3)
(5)
(7)
(7)
(5)
(3)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
Other Items
1
(13)
(11)
(6)
(29)
(56)
(65)
(67)
(48)
(23)
(13)
(102)
(66)
(5)
15
8
(54)
(145)
(176)
(71)
(43)
13
38
138
197
213
218
106
(0)
(77)
(40)
(20)
50
100
40
20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
1
N/A
(13)
N/A
(11)
+13%
(6)
+47%
(29)
-381%
(56)
-92%
(65)
-17%
(67)
-3%
(49)
+28%
(23)
+53%
(14)
+40%
(102)
-646%
(68)
+33%
(8)
+88%
13
N/A
5
-58%
(56)
N/A
(147)
-161%
(177)
-21%
(73)
+59%
(44)
+39%
12
N/A
37
+216%
135
+268%
192
+43%
206
+7%
211
+3%
101
-52%
(3)
N/A
(77)
-2 413%
(40)
+48%
(20)
+49%
50
N/A
100
+101%
40
-60%
20
-50%
(0)
N/A
(0)
N/A
(0)
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(0)
N/A
(0)
-7%
(0)
-6%
0
N/A
0
-80%
(0)
N/A
Financing Cash Flow
Net Issuance of Common Stock
46
44
44
156
115
104
104
(11)
54
79
83
144
79
68
67
8
53
115
116
210
165
102
97
1
10
10
26
83
217
218
212
184
79
94
89
67
29
13
8
0
0
0
7
26
26
27
43
90
91
91
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(15)
(15)
(15)
63
78
78
78
20
0
0
0
0
0
0
(33)
(33)
(49)
(57)
(24)
(32)
(16)
(0)
(0)
8
17
10
10
Other
(1)
(1)
(1)
(11)
(11)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45
45
45
45
40
40
40
40
0
0
0
0
(1)
(1)
(1)
(1)
(1)
(1)
(0)
Cash from Financing Activities
45
N/A
43
-6%
42
-1%
146
+244%
104
-28%
104
0%
104
+0%
(1)
N/A
65
N/A
79
+22%
83
+6%
144
+74%
79
-45%
68
-15%
67
-1%
8
-89%
53
+606%
115
+116%
116
+1%
210
+81%
165
-22%
102
-38%
97
-5%
(14)
N/A
(5)
+62%
(5)
-3%
89
N/A
161
+81%
295
+83%
296
+0%
232
-22%
249
+7%
143
-42%
159
+11%
134
-16%
107
-20%
69
-35%
20
-71%
15
-27%
(49)
N/A
(57)
-16%
(24)
+58%
(25)
-5%
9
N/A
25
+169%
26
+5%
50
+91%
106
+114%
100
-6%
100
0%
Change in Cash
Net Change in Cash
36
N/A
21
-41%
20
-7%
124
+532%
55
-56%
25
-54%
12
-54%
(98)
N/A
(19)
+81%
17
N/A
17
0%
16
-9%
(30)
N/A
(1)
+97%
138
N/A
44
-68%
79
+81%
24
-70%
(117)
N/A
71
N/A
38
-46%
73
+90%
36
-51%
(94)
N/A
(75)
+20%
(39)
+49%
43
N/A
53
+23%
158
+201%
46
-71%
81
+75%
137
+68%
1
-99%
38
+3 054%
(79)
N/A
(77)
+3%
(102)
-32%
(61)
+40%
(59)
+4%
(118)
-101%
(92)
+22%
(100)
-9%
(49)
+51%
(16)
+67%
(14)
+12%
(12)
+12%
9
N/A
71
+696%
98
+37%
132
+35%
Free Cash Flow
Free Cash Flow
(11)
N/A
(8)
+21%
(11)
-35%
(16)
-41%
(21)
-30%
(23)
-13%
(28)
-18%
(30)
-9%
(36)
-18%
(39)
-10%
(53)
-35%
(27)
+49%
(43)
-60%
(63)
-47%
55
N/A
28
-49%
80
+187%
55
-32%
(58)
N/A
(68)
-18%
(84)
-22%
(41)
+51%
(99)
-139%
(218)
-120%
(268)
-23%
(246)
+8%
(264)
-7%
(214)
+19%
(136)
+36%
(172)
-26%
(111)
+36%
(92)
+17%
(192)
-109%
(221)
-15%
(253)
-14%
(204)
+19%
(171)
+16%
(81)
+53%
(73)
+10%
(69)
+6%
(35)
+50%
(76)
-118%
(23)
+69%
(25)
-8%
(39)
-54%
(39)
+1%
(41)
-6%
(35)
+14%
(3)
+93%
32
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett